Transcriptional Profiles Predict Disease Outcome in Patients with Cutaneous T-Cell Lymphoma

Abstract excerpt

PURPOSE: Average survival of cutaneous T-cell lymphoma (CTCL) is associated with clinical stage at diagnosis, where stage I has a favorable survival prognosis, whereas patients with more advanced stages succumb to their disease within 5 years. Although the majority of patients present with an early-stage CTCL, 15% to 20% of them will inevitably progress. Current state-of-the-art clinical criteria cannot identify...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cutaneous lymphoproliferative disorders research
• Share to Lymphoma Diagnosis and Treatment
• Share to T-cell and Retrovirus Studies